Literature DB >> 7001853

Distribution of glial fibrillary acidic protein in central nervous system lesions of tuberous sclerosis.

K Stefansson, R Wollmann.   

Abstract

The distribution of glial fibrillary acidic protein (GFAP) in the central nervous system (CNS) lesions of tuberous sclerosis (TS) was examined using antiserum against GFAP and the peroxidase antiperoxidase method of Sternberger. In cortical tubers there were islands of gemistocytic astrocytes staining intensely for GFAP and occasional giant cells having some cytoplasmic staining. The majority of the cortical giant cells had no GFAP. The islands were separated by areas devoid of astrocytes with perikaryal staining. A faintly staining fibrous network was found between these islands. The majority of cells in the subependymal nodules stained. The retinal phakoma stained but not as intensely as the subependymal nodules. There was no staining whatsoever in the giant cell subependymal tumors. Absence of GFAP staining in the subependymal giant cell tumors makes their classification as astrocytomas less certain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001853     DOI: 10.1007/bf00688011

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

1.  The topographical distribution of S-100 and GFA proteins in the adult rat brain: an immunohistochemical study using horseradish peroxidase-labelled antibodies.

Authors:  S K Ludwin; J C Kosek; L F Eng
Journal:  J Comp Neurol       Date:  1976-01-15       Impact factor: 3.215

2.  The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors.

Authors:  J H Deck; L F Eng; J Bigbee; S M Woodcock
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

3.  The protein composition of bovine myelin-free axons.

Authors:  G H De Vries; L F Eng; D L Lewis; M G Hadfield
Journal:  Biochim Biophys Acta       Date:  1976-07-19

4.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.

Authors:  L F Eng; L J Rubinstein
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

5.  Fine structure of atypical cells in tuberous sclerosis.

Authors:  C Arseni; M Alexianu; L Horvat; D Alexianu; A Petrovici
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

6.  [Ultrastructural study of cerebral lesions in tuberous sclerosis (author's transl)].

Authors:  J L Dumas; J Poirier; R Escourolle
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

7.  Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases.

Authors:  J J Kepes; L J Rubinstein; L F Eng
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

8.  Subependymal giant cell tumor of tuberose sclerosis. A light and ultrastructural study.

Authors:  J P de Chadarévian; R D Hollenberg
Journal:  J Neuropathol Exp Neurol       Date:  1979-07       Impact factor: 3.685

9.  Radial glia in the human fetal cerebrum: a combined Golgi, immunofluorescent and electron microscopic study.

Authors:  B H Choi; L W Lapham
Journal:  Brain Res       Date:  1978-06-16       Impact factor: 3.252

10.  Ultrastructural localization of glial fibrillary acidic protein in mouse cerebellum by immunoperoxidase labeling.

Authors:  M Schachner; E T Hedley-Whyte; D W Hsu; G Schoonmaker; A Bignami
Journal:  J Cell Biol       Date:  1977-10       Impact factor: 10.539

  10 in total
  10 in total

1.  Cortical tubers demonstrate reduced immunoreactivity for synapsin I.

Authors:  C F Lippa; D Pearson; T W Smith
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

2.  An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system.

Authors:  J A Royds; J W Ironside; C B Taylor; D I Graham; W R Timperley
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

3.  Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors.

Authors:  E P Henske; L L Wessner; J Golden; B W Scheithauer; A O Vortmeyer; Z Zhuang; A J Klein-Szanto; D J Kwiatkowski; R S Yeung
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

4.  Biological behavior and tumorigenesis of subependymal giant cell astrocytomas.

Authors:  S K Kim; K C Wang; B K Cho; H W Jung; Y J Lee; Y S Chung; J Y Lee; S H Park; Y M Kim; G Choe; J G Chi
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

5.  Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study.

Authors:  J M Bonnin; L J Rubinstein; S C Papasozomenos; P J Marangos
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Subependymal giant-cell tumor: astrocytic or neuronal?

Authors:  Y Nakamura; L E Becker
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

7.  Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.

Authors:  T Hirose; B W Scheithauer; M B Lopes; H A Gerber; H J Altermatt; M J Hukee; S R VandenBerg; J C Charlesworth
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Distribution of the neuronal specific protein, 14-3-2, in central nervous system lesions of tuberous sclerosis.

Authors:  K Stefansson; R Wollmann
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

9.  Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue.

Authors:  H V Vinters; R S Fisher; M E Cornford; V Mah; D L Secor; M J De Rosa; Y G Comair; W J Peacock; W D Shields
Journal:  Childs Nerv Syst       Date:  1992-02       Impact factor: 1.475

Review 10.  The role of glia in epilepsy, intellectual disability, and other neurodevelopmental disorders in tuberous sclerosis complex.

Authors:  Michael Wong
Journal:  J Neurodev Disord       Date:  2019-12-16       Impact factor: 4.025

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.